# US Oncology, Inc. IRB – FDA Inspection, Jul 7, 2017

Source: https://www.keypedia.com/records/fda_inspections/us-oncology-inc-irb/5bff253f-40c4-40c1-bbb0-bc302932b425
Source feed: FDA_Inspections

> FDA inspection 1023482 of US Oncology, Inc. IRB, July 07, 2017. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1023482
- Company Name: US Oncology, Inc. IRB
- Inspection Date: 2017-07-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 674761 - 2010-07-28
- FDA Inspection 569265 - 2009-03-12

## Related Officers

- [Company Rep](https://www.keypedia.com/people/zerita-white/82b19f0c-bd17-4a44-8523-8986f38851a8)

Company: https://www.keypedia.com/companies/us-oncology-inc-irb/8d207e05-2aac-43c6-a6fd-6c3b94995997

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c